Key statistics
On Friday, Lifecore Biomedical Inc (LDE:FRA) closed at 6.55, -16.03% below its 52-week high of 7.80, set on Feb 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.55 |
---|---|
High | 6.55 |
Low | 6.55 |
Bid | 6.90 |
Offer | 7.05 |
Previous close | 6.95 |
Average volume | 0.00 |
---|---|
Shares outstanding | 36.83m |
Free float | 34.87m |
P/E (TTM) | 188.96 |
Market cap | 257.05m USD |
EPS (TTM) | 0.0369 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:05 GMT.
More ▼
Announcements
- Lifecore Biomedical Hosts Virtual Investor Day
- Lifecore Biomedical to Present at Stephens Annual Investment Conference
- Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
- Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
- Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
- Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
- Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
- Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
- Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
- Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
More ▼